Myanmar FDA registration 47dea20bcf29deba0f7a0e00a40a619e
Bond Primary Antibody Diluent
Myanmar·Leica·Leica Biosystems Newcastle Ltd·Registered October 19, 2022Device classification
- Brand Name
- Leica
Registration information
- Analysis ID
- 47dea20bcf29deba0f7a0e00a40a619e
- Registration Date
- October 19, 2022
Manufacturer
Authorized Representative
About this record
Access comprehensive regulatory information for Bond Primary Antibody Diluent in the Myanmar medical device market through Pure Global AI's free database. This medical device is registered under FDA ID 47dea20bcf29deba0f7a0e00a40a619e and manufactured by Leica Biosystems Newcastle Ltd. The device was registered on October 19, 2022.
This page provides complete registration details including manufacturer information, authorized representative details, and regulatory compliance data from the official Myanmar FDA medical device database. Pure Global AI offers free access to Myanmar's complete medical device registry.
Free DatabasePowered by Pure Global AIFDA Official Data